Skip to content
10-Q

Quarterly Report

Enveric Biosciences, Inc. ENVB

0001493152-25-023540

← back to feed
Filed
Nov 14, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 12, 2025 596.98K sh
Shares Diluted Q3 2025 · Sep 30, 2025 313.24K sh
Shares Diluted Q3 2025 · Sep 30, 2025 226.4K sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 48.35K sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 37.62K sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$6.36M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$6.41M
Stockholders Equity Q3 2025 · Sep 30, 2025 $3.46M
Stockholders Equity Q3 2025 · Jun 30, 2025 $2.18M
Stockholders Equity Q3 2025 · Mar 31, 2025 $3.92M
Stockholders Equity Q3 2025 · Dec 31, 2024 $1.59M
Stockholders Equity Q3 2025 · Sep 30, 2024 $3.95M
Stockholders Equity Q3 2025 · Jun 30, 2024 $5.41M
Stockholders Equity Q3 2025 · Mar 31, 2024 $6.48M
Stockholders Equity Q3 2025 · Dec 31, 2023 $1.96M
Current Liabilities Q3 2025 · Sep 30, 2025 $905.89K
Current Liabilities Q3 2025 · Dec 31, 2024 $1.49M
Current Assets Q3 2025 · Sep 30, 2025 $4.17M
Current Assets Q3 2025 · Dec 31, 2024 $2.73M
Total Assets Q3 2025 · Sep 30, 2025 $4.36M
Total Assets Q3 2025 · Dec 31, 2024 $3.08M
Eps Diluted Q3 2025 · Sep 30, 2025 −$10.81
Eps Diluted Q3 2025 · Sep 30, 2025 −$35.74
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$43.10
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$170.67
Eps Basic Q3 2025 · Sep 30, 2025 −$10.81
Eps Basic Q3 2025 · Sep 30, 2025 −$35.74
Eps Basic restated Q3 2025 · Sep 30, 2024 −$43.10
Eps Basic restated Q3 2025 · Sep 30, 2024 −$170.67
Rd Expense Q3 2025 · Sep 30, 2025 $402.42K
Rd Expense Q3 2025 · Sep 30, 2025 $2.41M
Rd Expense restated Q3 2025 · Sep 30, 2024 $802.72K
Rd Expense restated Q3 2025 · Sep 30, 2024 $1.87M
Net Income Q3 2025 · Sep 30, 2025 −$1.87M
Net Income Q3 2025 · Sep 30, 2025 −$6.58M
Net Income Q3 2025 · Jun 30, 2025 −$2.52M
Net Income Q3 2025 · Mar 31, 2025 −$2.18M
Net Income Q3 2025 · Sep 30, 2024 −$2.08M
Net Income Q3 2025 · Sep 30, 2024 −$6.42M
Net Income Q3 2025 · Jun 30, 2024 −$1.88M
Net Income Q3 2025 · Mar 31, 2024 −$2.46M
Operating Income Q3 2025 · Sep 30, 2025 −$1.87M
Operating Income Q3 2025 · Sep 30, 2025 −$6.58M
Operating Income Q3 2025 · Sep 30, 2024 −$2.08M
Operating Income Q3 2025 · Sep 30, 2024 −$6.46M